JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Scope & Guideline

Elevating understanding of cardiovascular dynamics at the cellular scale.

Introduction

Delve into the academic richness of JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0022-2828
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1970 to 2024
AbbreviationJ MOL CELL CARDIOL / J. Mol. Cell. Cardiol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The Journal of Molecular and Cellular Cardiology focuses on advancing the understanding of molecular and cellular mechanisms underlying cardiovascular health and disease. Its scope encompasses a wide range of topics, from cellular signaling pathways to the development of innovative therapeutic strategies.
  1. Molecular Mechanisms in Cardiac Function:
    Research on the molecular pathways that regulate cardiac function, including signaling cascades, gene expression, and metabolic processes that influence heart health.
  2. Cardiovascular Disease Mechanisms:
    Studies exploring the pathophysiology of various cardiovascular diseases such as heart failure, arrhythmias, and cardiomyopathies, emphasizing the cellular and molecular alterations involved.
  3. Innovative Therapeutic Strategies:
    Development and evaluation of novel therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions aimed at repairing or regenerating cardiac tissue.
  4. Cardiac Regeneration and Repair:
    Research focused on the mechanisms underlying cardiac regeneration, including the role of stem cells, extracellular matrix, and signaling pathways in promoting tissue repair.
  5. Sex Differences in Cardiovascular Health:
    Investigation of how biological sex influences cardiovascular health, disease prevalence, and treatment response, with a focus on molecular and cellular differences.
  6. Integrative Omics Approaches:
    Utilization of multi-omics technologies (genomics, proteomics, metabolomics) to provide comprehensive insights into cardiovascular biology and disease mechanisms.
The Journal of Molecular and Cellular Cardiology is witnessing exciting developments in several emerging research themes that reflect the evolving landscape of cardiovascular science. The following sections outline the key trends that have gained momentum in recent publications.
  1. Cardiovascular Metabolism:
    An increasing focus on the role of metabolic pathways in cardiac health and disease, particularly how metabolic dysregulation contributes to conditions such as obesity, diabetes, and heart failure.
  2. Gene Editing and Gene Therapy:
    A surge in research utilizing CRISPR and other gene editing technologies to explore genetic underpinnings of cardiovascular diseases and develop targeted gene therapies.
  3. Extracellular Vesicles and Cell Communication:
    Emerging studies investigating the role of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic agents in cardiovascular diseases.
  4. Inflammation and Immunology in Cardiology:
    Growing interest in understanding the immune response in cardiovascular diseases, particularly how inflammation contributes to disease progression and the potential for immunomodulatory therapies.
  5. Single-Cell and Multi-Omics Approaches:
    The adoption of single-cell sequencing and integrative multi-omics approaches is on the rise, allowing for a more detailed understanding of cellular heterogeneity and the molecular landscape of cardiovascular diseases.
  6. Personalized Medicine and Cardiovascular Health:
    A trend towards personalized approaches to cardiovascular disease management, incorporating genetic, molecular, and clinical data to tailor treatments to individual patients.

Declining or Waning

While the Journal of Molecular and Cellular Cardiology has consistently focused on various aspects of cardiovascular research, some themes appear to be declining in prominence based on recent publication trends. This section highlights those areas that are receiving less attention.
  1. Traditional Pharmacology:
    There is a noticeable reduction in studies centered on traditional pharmacological approaches to treating heart disease, as the field shifts towards more innovative and targeted therapeutic strategies.
  2. Basic Animal Models:
    Research using basic animal models without advanced genetic manipulations or disease modeling techniques has decreased, reflecting a broader trend towards more sophisticated and translational modeling approaches.
  3. Cardiac Imaging Techniques:
    While imaging remains a crucial tool in cardiology, there is less emphasis on traditional imaging studies (e.g., echocardiography) in favor of molecular and cellular investigations that provide deeper mechanistic insights.
  4. Aging Research in Cardiovascular Disease:
    Although aging is a critical factor in cardiovascular health, publications specifically addressing aging-related mechanisms in a standalone manner have diminished, likely due to a shift towards integrated approaches that consider aging as a variable within broader studies.

Similar Journals

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Shaping the Future of Experimental Pathology
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

npj Regenerative Medicine

Bridging Disciplines for Medical Transformation.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.

Nature Cardiovascular Research

Connecting researchers and practitioners in cardiovascular health.
Publisher: SPRINGERNATUREISSN: Frequency: 12 issues/year

Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.

World Journal of Cardiology

Fostering collaboration and discovery in cardiovascular research.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Elevating Knowledge in Physiology and Pharmacology
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0008-4212Frequency: 12 issues/year

Canadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.

CIRCULATION RESEARCH

Exploring the heart of cardiovascular health and disease.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

BIOSCIENCE REPORTS

Driving Progress in Biochemical and Cellular Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Elevating Research in Receptor Dynamics
Publisher: TAYLOR & FRANCIS LTDISSN: 1079-9893Frequency: 6 issues/year

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

International Heart Journal

Advancing Cardiovascular Knowledge Globally
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Nepalese Heart Journal

Elevating Cardiology Practices in Nepal and Beyond
Publisher: CARDIAC SOC NEPALISSN: 2091-2978Frequency: 1 issue/year

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.